Eli Lilly And Co (0Q1G)
LSE
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current 0Q1G market cap is 77.68B. The company's latest EPS is USD 5.5202 and P/E is 166.30.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.32B | 24.56B | 28.32B | 28.54B | 34.12B |
| Operating Income | 5.47B | 6.06B | 6.66B | 7.37B | 6.46B |
| Net Income | 8.32B | 6.19B | 5.58B | 6.24B | 5.24B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 39.29B | 46.63B | 48.81B | 49.49B | 64.01B |
| Total Liabilities | 36.59B | 40.81B | 39.65B | 38.71B | 53.14B |
| Total Equity | 2.7B | 5.83B | 9.15B | 10.78B | 10.86B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 4.84B | 6.5B | 7.26B | 7.08B | 4.24B |
| Investing | -8.08B | -2.26B | -2.76B | -3.26B | -7.15B |
| Financing | -2.32B | -3.14B | -4.13B | -5.41B | 3.5B |
| Market Cap | 77.68B |
| Price to Earnings Ratio | 166.30 |
| Price to Sales Ratio | 25.54 |
| Price to Cash Ratio | 309.18 |
| Price to Book Ratio | 80.22 |
| Dividend Yield | - |
| Shares Outstanding | 949.31M |
| Average Volume (1 week) | 1.24k |
| Average Volume (1 Month) | 739 |
| 52 Week Change | 0.00% |
| 52 Week High | 81.83 |
| 52 Week Low | 81.83 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Eli Lilly And Co |
| Address |
334 north senate avenue indianapolis, indiana 46204 |
| Website | https://www.lilly.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
